Scientists have discovered that cervical cancer can be divided into two distinct molecular subgroups—one far more aggressive than the other—as part of the largest "omics" study of its kind, led by researchers at UCL and ...
Oct 21, 2022
0
53
Virginia Tech researchers from the Department of Biomedical Engineering and Mechanics and the Department of Biochemistry have discovered a characteristic of a common oral bacterium that relocates to pancreatic cancer tumors ...
Oct 18, 2022
0
49
About one-fourth of recurrent estrogen receptor-positive (ER+) breast cancers lose ER expression, which renders them resistant to endocrine therapy and able to grow uncontrolled. A team of researchers at Baylor College of ...
Oct 17, 2022
0
51
Breast cancers that emerge within five years of giving birth are more likely to spread and become deadly. Additionally, a new study shows that recent childbirth alone is an independent risk factor for breast cancer progression.
Oct 14, 2022
0
63
Investigators from Rutgers Cancer Institute of New Jersey, the state's leading cancer center and only National Cancer Institute-Designated Comprehensive Cancer Center, together with RWJBarnabas Health, examined the microbiome ...
Oct 10, 2022
0
50
Babies with leukemia could get an array of new treatments after scientists used genetic engineering to reproduce a gene defect found in the disease.
Oct 7, 2022
0
64
Glioblastoma, the most common cancerous brain tumor in adults, is an aggressive disease—patients survive an average of just 15 months once they are diagnosed. Despite more than two decades of research on the causes and ...
Sep 26, 2022
1
59
Fat cells, or adipocytes, that grow in close proximity to breast cancers can shift into other cell types that promote tumor growth, a new study by UT Southwestern researchers suggests. The findings, published in Cell Reports, ...
Sep 23, 2022
0
694
Researchers have uncovered a novel pathway that explains how cancer cells become resistant to chemotherapies, which in turn offers a potential solution for preventing chemo-resistance.
Sep 20, 2022
0
43
Immune checkpoint inhibitor (ICI) therapy is a type of treatment for melanoma, the deadliest form of skin cancer, which blocks proteins on tumor or immune cells that prevent the immune system from killing cancer cells.
Sep 19, 2022
0
1486
